[Activ Surgical] Activ Surgical Announces Completion of First In-Human Procedures Demonstrating Impa
[Activ Surgical]
Media Contact:
Heath Meyer
heath@teamseismic.com
858-768-1527
Digital
Surgery Pioneer Conducts Multi-Patient Trial at UTHealth Houston
BOSTON — November 3, 2021 — Activ
Surgical™, a digital surgery pioneer, today announced the completion of its
first in-human surgery clinical trial utilizing the company’s
technology-as-a-service bundle—the ActivInsights™ augment reality (AR)-based
software suite and the ActivSight™ imaging module. Procedures for the study at
The University of Texas Health Science Center at Houston (UTHealth Houston)
were led by Dr. Erik Wilson, professor in the Department of Surgery at McGovern
Medical School at UTHealth and a leading bariatric, endoluminal and robotic
general surgeon; and Dr. Shinil Shah, associate professor at UTHealth Houston
and a preeminent general surgeon with expertise in advanced gastrointestinal
surgery. The safety and feasibility study was conducted across bariatric,
colorectal and gallbladder procedures—surgeries in which intraoperative
assessment of perfusion and anatomic structures are critical to prevent costly
and life-threatening complications.
During the study, Dr. Wilson and Dr. Shah
conducted a number of procedures using the ActivInsights software suite along
with the company’s interoperable imaging module, ActivSight. Together,
ActivInsights and ActivSight delivered Perfusion View Insights, which allowed
Dr. Wilson and Dr. Shah the ability to see blood flow and perfusion in real
time, without the use of traditional dyes.
“Patient safety is always our number one
priority in the operating room,” said Dr. Wilson. “Our study using the
ActivInsights AR-based software suite and the ActivSight imaging module
revealed no safety issues and showed it has the potential to improve patient
outcomes and reduce surgical complications. It was seamless for our team to use
and provided physiological information in real-time during these first in-human
procedures.”
The UTHealth Houston study’s procedures
were performed at Memorial Hermann-Texas Medical Center and Memorial Hermann
Sugar Land Hospital. The study with UTHealth Houston is the first of several
in-human trials Activ Surgical has planned around the world with leading
healthcare systems and renowned surgeons in 2021. The company received Food and
Drug Administration (FDA) clearance for the ActivSight interoperable imaging
module in April and expects its software suite to be commercially available to
surgeons around the world in 2022.
“We are grateful to Dr. Wilson and Dr. Shah
to be the first to participate in these imperative in-human safety and
feasibility studies,” said Todd Usen, chief executive officer, Activ Surgical.
“While HD and 4K have taken what a physician or a television viewer can see,
and enhances it, the ActivInsights software suite and ActivSight imaging module
takes this advancement a step further by allowing surgeons to see what they
currently cannot via present-day technology. These trials, coupled with our
recent clearance from the FDA, are critical steps in the rollout of our
technology that will improve patient outcomes and safety in the OR and help to
democratize surgical care across the globe.”
For more information about Activ Surgical
and the ActivInsights AR-based software suite, please visit
www.activsurgical.com.
–
About Activ Surgical
Activ Surgical is the pioneering digital
surgery company that completed the world’s first autonomous robotic surgery of
soft tissue in 2018. The company is revolutionizing surgical vision, enabling a
future of augmented reality-based and artificial intelligence-driven surgery
that is safe, smart, and accessible to all. Its patent-protected surgical
software platform–ActiveEdge™–is being designed to reduce unintended and
preventable surgical errors by enhancing a surgeon’s intraoperative decision
making via the aggregation of surgical data from around the world. Activ
Surgical is privately held, and backed by Cota Capital, BAM Funds, Magnetar
Capital, MINT Venture Partners, Castor Ventures, Dream One Vision, NVIDIA, DNS
Capital, Tao Capital Partners, LRVHealth, Rising Tide VC, GreatPoint Ventures
(GPV) and ARTIS Ventures. Learn more at www.activsurgical.com.